What is the address of Dr. SCHEIR PETRA - Gynaecologie?

The registered office of Dr. SCHEIR PETRA - Gynaecologie is located at Hogerlucht 116C, 9600 Ronse.

Is Dr. SCHEIR PETRA - Gynaecologie still active?

Yes. According to the CBE (27 September 2026) Dr. SCHEIR PETRA - Gynaecologie is active, legal situation “Normale toestand”, started on 4 January 2010.

Is Dr. SCHEIR PETRA - Gynaecologie registered on Peppol?

Yes, Dr. SCHEIR PETRA - Gynaecologie is registered on the Peppol network with ID 0208:0821912771.

What is the enterprise number of Dr. SCHEIR PETRA - Gynaecologie?

The enterprise number of Dr. SCHEIR PETRA - Gynaecologie is BE0821912771.

When was Dr. SCHEIR PETRA - Gynaecologie founded?

Dr. SCHEIR PETRA - Gynaecologie was founded on 4 January 2010.

Who are the directors of Dr. SCHEIR PETRA - Gynaecologie?

According to the 2025 annual accounts, the directors of Dr. SCHEIR PETRA - Gynaecologie are: Petra Scheir.

Is Dr. SCHEIR PETRA - Gynaecologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 January 2010; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did Dr. SCHEIR PETRA - Gynaecologie make in 2025?

Dr. SCHEIR PETRA - Gynaecologie posted a profit after taxes of € 113,655 in financial year 2025.

What is the revenue of Dr. SCHEIR PETRA - Gynaecologie?

As a small company, Dr. SCHEIR PETRA - Gynaecologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 169,220.

Dr. SCHEIR PETRA - Gynaecologie (Private Limited) - Ronse

Dossier Dr. SCHEIR PETRA - Gynaecologie, printed on 27 September 2026 from databakkes.be/en/0821912771/dr-scheir-petra-gynaecologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. SCHEIR PETRA - Gynaecologie from Ronse, company number BE0821912771, closed financial year 2025 with a result of € 113,655 after tax. For that financial year Dr. SCHEIR PETRA - Gynaecologie recorded a gross margin of € 169,220 and equity of € 659,776. Compared with financial year 2024, the result moved from € 104,753 to € 113,655. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.

What it is worth Growing

€ 659,776

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 113,655

▲ 8% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 572,008

▲ € 466,601 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 49,300 paid out

43 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 46,002

▼ 13% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 35,935

▼ 27% vs 2024

€ 13,989 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 5,251

▼ 47% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 11,366

▼ 47% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 171,002 Gross margin 2022: € 171,002 First fiscal year in the series	€ 157,896 Gross margin 2023: € 157,896 ▼ 8% vs 2022 (€ 171,002) Unfavourable step	€ 160,507 Gross margin 2024: € 160,507 ▲ 2% vs 2023 (€ 157,896) Favourable step	€ 169,220 Gross margin 2025: € 169,220 ▲ 5% vs 2024 (€ 160,507) Favourable step	▲ 5%
Profit after taxes	€ 110,670 Profit after taxes 2022: € 110,670 First fiscal year in the series	€ 108,068 Profit after taxes 2023: € 108,068 ▼ 2% vs 2022 (€ 110,670) Unfavourable step	€ 104,753 Profit after taxes 2024: € 104,753 ▼ 3% vs 2023 (€ 108,068) Unfavourable step	€ 113,655 Profit after taxes 2025: € 113,655 ▲ 8% vs 2024 (€ 104,753) Favourable step	▲ 8%
Equity	€ 493,594 Equity 2022: € 493,594 First fiscal year in the series	€ 527,754 Equity 2023: € 527,754 ▲ 7% vs 2022 (€ 493,594) Favourable step	€ 595,421 Equity 2024: € 595,421 ▲ 13% vs 2023 (€ 527,754) Favourable step	€ 659,776 Equity 2025: € 659,776 ▲ 11% vs 2024 (€ 595,421) Favourable step	▲ 11%
Total debts	€ 112,164 Total debts 2022: € 112,164 First fiscal year in the series	€ 97,274 Total debts 2023: € 97,274 ▼ 13% vs 2022 (€ 112,164) Favourable step	€ 145,445 Total debts 2024: € 145,445 ▲ 50% vs 2023 (€ 97,274) Unfavourable step	€ 114,108 Total debts 2025: € 114,108 ▼ 22% vs 2024 (€ 145,445) Favourable step	▼ 22%
Cash	€ 549,327 Cash 2022: € 549,327 First fiscal year in the series	€ 165,282 Cash 2023: € 165,282 ▼ 70% vs 2022 (€ 549,327) Unfavourable step	€ 105,407 Cash 2024: € 105,407 ▼ 36% vs 2023 (€ 165,282) Unfavourable step	€ 572,008 Cash 2025: € 572,008 ▲ € 466,601 vs 2024 (€ 105,407) Favourable step	▲ € 466,601
Retained profit	€ 474,994 Retained profit 2022: € 474,994 First fiscal year in the series	€ 507,294 Retained profit 2023: € 507,294 ▲ 7% vs 2022 (€ 474,994) Favourable step	€ 576,821 Retained profit 2024: € 576,821 ▲ 14% vs 2023 (€ 507,294) Favourable step	€ 641,176 Retained profit 2025: € 641,176 ▲ 11% vs 2024 (€ 576,821) Favourable step	▲ 11%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 73,907 Dividend 2023: € 73,907 Unchanged (€ 0) Unchanged	€ 37,087 Dividend 2024: € 37,087 ▼ 50% vs 2023 (€ 73,907) Unchanged	€ 49,300 Dividend 2025: € 49,300 ▲ 33% vs 2024 (€ 37,087) Unchanged	▲ 33%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 49,511 Bank debt 2024: € 49,511 Unchanged (€ 0) Unfavourable step	€ 35,935 Bank debt 2025: € 35,935 ▼ 27% vs 2024 (€ 49,511) Favourable step	▼ 27%
Balance sheet total	€ 605,758 Balance sheet total 2022: € 605,758 First fiscal year in the series	€ 625,029 Balance sheet total 2023: € 625,029 ▲ 3% vs 2022 (€ 605,758) Unchanged	€ 740,866 Balance sheet total 2024: € 740,866 ▲ 19% vs 2023 (€ 625,029) Unchanged	€ 773,884 Balance sheet total 2025: € 773,884 ▲ 4% vs 2024 (€ 740,866) Unchanged	▲ 4%

Key figures of Dr. SCHEIR PETRA - Gynaecologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. SCHEIR PETRA - Gynaecologie?

What happened at Dr. SCHEIR PETRA - Gynaecologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 15, 2026 New annual accounts for financial year 2025: profit of € 113,655 (▲ 8% vs 2024). Source: NBB ↗
Jan 14, 2010 New establishment in Ronse. KBO
Jan 14, 2010 New establishment in Ronse. KBO
Jan 4, 2010 Start of the company according to the CBE. KBO

In short

From € 110,670 profit in 2022 to € 113,655 profit in 2025.

Paid € 190,572 in corporate taxes since 2022.

Best year ever: 2025, with € 113,655 profit.

Paid out € 160,293 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. SCHEIR PETRA - Gynaecologie? We notify you, reason included.

Follow Dr. SCHEIR PETRA - Gynaecologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Petra Scheir

Dr. SCHEIR PETRA - Gynaecologie

Behind Dr. SCHEIR PETRA - Gynaecologie is Petra Scheir.

See the full network in the app

Directors

According to the 2025 annual accounts

Petra Scheir

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Hogerlucht 116C

9600 Ronse

2.183.986.276

Stefaan Modest Glorieuxlaan 55

9600 Ronse

Active since 14 January 2010

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0821.912.771
VAT number: BE 0821.912.771
Registered office: Hogerlucht 116C, 9600 Ronse
Names & denominations: Dr. SCHEIR PETRA - Gynaecologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 January 2010
Peppol: Active · Active since 19 Jul 2025

View on CBE Public ↗ Annual accounts (NBB) ↗